Developer docs
API playgroundTry for free, no card

Search company profiles

Curiox Biosystems

Full company profile

uuid0002bvc

Namestring
Curiox Biosystems
Legal namestring
Curiox Biosystems, Inc.
Websiteurl
curiox.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Curiox Biosystems develops and manufactures automation solutions for suspension cell sample preparation, replacing traditional centrifugation with its proprietary C-FREE technology platform. C-FREE uses laminar flow physics and software-controlled pipetting to gently wash and mix cells and beads without centrifugation, minimizing mechanical stress, improving cell retention (reportedly up to 90.6% versus 10.5% with centrifugation), and reducing operator variability. The portfolio spans the Pluto ALPHA compact benchtop washer, the Pluto Workstation family (LT/MT/HT variants with up to 96-channel pipetting) for integrated antibody cocktailing, cell staining, and washing, and Pluto Code, a software library that deploys C-FREE wash physics onto existing Opentrons and Hamilton liquid handlers without additional hardware. Supporting tools include the Antibody Cocktailing Wizard and Workflow Wizard for protocol standardization and audit-traceable execution, plus legacy Laminar Wash HT/AUTO/MINI systems and Drop Array consumables.

The company monetizes through direct enterprise sales of hardware systems, recurring consumables (plates, reagents, accessories), and emerging enterprise software licensing via Master Software License Agreements for Pluto Code. Go-to-market is enterprise field sales targeting pharmaceutical and biotech companies, contract research organizations, academic core facilities, and cell-therapy manufacturers, with technical evaluation cycles of 4-8 weeks and quote-based pricing. Named customers include AbbVie, AstraZeneca, Amgen, Pfizer, Novartis, Bristol-Myers Squibb, Sanofi, GSK, Merck, Takeda, Kite Pharma, Stanford, NIST, IQVIA, Charles River Laboratories, Eurofins, 10x Genomics, and IMU Biosciences. Curiox completed a $15 million Series C led by Luha Private Equity in March 2022 (following a prior $15M Series B in 2019) to fund global operations expansion; it has since obtained 21 CFR Part 11 compliance, expanded presence across the US, UK, Switzerland, Germany, and France, and is listed on KOSDAQ (445680) while remaining operationally a venture-backed life-sciences tools firm with 51-100 employees.

Short descriptiontext

Curiox Biosystems provides the C-FREE platform and Pluto product family of automated, centrifuge-free cell washing and antibody cocktailing workstations used by pharmaceutical companies, CROs, academic core facilities, and cell-therapy developers to standardize flow cytometry sample preparation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
flow cytometry automation, cell sample preparation, centrifuge-free washing, antibody cocktailing systems, liquid handling workstations
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Laboratory Apparatus & Furniture3821
Product category
Laboratory Automation Instrumentation
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pluto Hardware Systems
TypeHardware Sales
Description

Sale of Pluto Workstation (HT/MT/LT variants), Pluto ALPHA automated cell washing systems, and associated accessories and consumables. Systems range from compact benchtop to high-throughput enterprise workstations.

curiox.com
2Pluto Code Software Licensing
TypeLicensing Royalties
Description

Enterprise software licensing model for Pluto Code deployment across liquid-handling workstations. Master Software License Agreement enables enterprise-scale activation across additional workstations and sites under master terms.

globenewswire.com
3Consumables and Accessories
TypeHardware Sales
Description

Ongoing sales of plates, reagents, and consumables for use with Pluto systems. Includes Laminar Wash plates, Drop Array products, and lab accessories.

curiox.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1C-FREE
Description

Automation-ready platform that performs cell washing and mixing without centrifugation, powering the Pluto product family.

curiox.com
+5 more records
Core offering1 text field

Curiox Biosystems develops and sells the C-FREE Technology Platform, an automation-ready system for centrifuge-free cell washing and sample preparation using proprietary laminar flow principles. The company sells the Pluto Workstation family (low, mid, and high throughput variants), the compact Pluto ALPHA cell washer, the Pluto Code software for deploying C-FREE on existing liquid handlers, and supporting Laminar Wash plate-based systems, consumables, and accessories to pharmaceutical, biotech, CRO, cell therapy, and academic customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Cell retention rates increase to 90.6% vs 10.5% with centrifugation for lymphocyte recovery
+7 more records
Product overview1 text field

Curiox Biosystems offers the C-FREE Technology Platform, an automation-ready system for centrifuge-free cell washing and sample preparation. The portfolio includes Pluto ALPHA (compact cell washing), Pluto LT/MT/HT Workstations (low to high throughput automated workstations for antibody cocktailing and cell washing), and Pluto Code (software for integrating C-FREE into existing liquid handlers). Supporting this are Laminar Wash technology (plate-based gentle cell washing) and software tools like Antibody Cocktailing Wizard and Workflow Wizard. Legacy products include Laminar Wash HT2000/HT2100, AUTO 1000, and MINI1000 systems. The platform uses proprietary laminar flow principles to replace centrifugation with software-controlled pipette-based washing, enabling consistent, reproducible cell preparation for flow cytometry, single-cell sequencing, and cell therapy applications.

Product and service7 records
1Pluto Workstation
CategoryAutomated Liquid Handling Workstation
Description

Automated liquid handler workstation for antibody cocktailing, cell staining, and washing. Available in three throughput variants: LT (8-channel head, up to 32 wells), MT (24-channel head, up to 72 wells), and HT (96-channel head, up to 96 wells). Supports 40+ parameter panels with temperature-controlled antibody handling, liquid-level detection, automated tip selection, full audit trail, and traceability for regulated environments.

2Pluto ALPHA
CategoryCompact Cell Washing Instrumentation
Description

Compact liquid handler that automates cell washing for up to 96 wells inside biosafety cabinets, using pre-set protocols (Light, Moderate, Heavy). Eliminates centrifugation variability, preserves cell integrity, and targets smaller labs seeking affordable entry into automated, reproducible cell preparation.

3Pluto Code
CategoryLaboratory Automation Software
Description

Software library that brings C-FREE centrifuge-free cell washing technology directly to existing liquid handling platforms (Opentrons, Hamilton) via a portable script library. Enables enterprise-scale deployment of C-FREE wash physics across customer workstations and sites via Master Software License Agreements, requiring no additional hardware upgrades.

4Laminar Wash HT2000
CategoryPlate-based Cell Washing System
Description

Automated plate-based laminar wash system for suspension cell sample preparation with robotic integration capability for high-throughput applications. Uses proprietary laminar flow to gently wash suspension cells without centrifugation, minimizing mechanical stress and improving viability versus traditional centrifugation workflows.

5Laminar Wash AUTO 1000
CategoryAutomated Sample Preparation Workstation
Description

All-in-one fully automated workstation using a suspension-cell sample preparation method that eliminates centrifugation. Provides walkaway capability with full traceability for suspension cell handling in flow cytometry workflows.

6Laminar Wash MINI1000
CategoryCompact Cell Washing System
Description

Compact laminar wash system using a proprietary 16-well wall-less strip for daily operation and CITE-Seq protocol demonstrations in lower-throughput lab environments.

7Drop Array
CategoryLab Accessory
Description

Accessory product line for specialized array-based applications using Curiox drop-array technology, supporting lab workflows requiring array-based sample handling.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Major Global Pharmaceutical Organization
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2026-04-22
Description

Master Software License Agreement for Pluto Code deployment across customer's liquid-handling workstations. Enables enterprise-scale activation across additional workstations and sites under master terms. Signals that centrifuge-free automation has moved beyond early adoption into enterprise-level deployment.

globenewswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Standard BioTools sells mass cytometry (Helios/cyTOF) and high-parameter flow cytometry systems plus imaging mass cytometry. Overlaps with Curiox in flow cytometry sample preparation, particularly for high-dimensional immunophenotyping workflows.

TypeDirect peer
Description

Opentrons makes accessible bench-top liquid-handling robots (OT-2, Flex) widely used in pharma and academic labs. Curiox's Pluto Code runs natively on Opentrons hardware, so the two are both collaborators and adjacent competitors in the affordable lab-automation category.

TypeBroad incumbent
Description

Tecan is a global leader in laboratory automation (Freedom EVO, Fluent) and detection instruments for life sciences and diagnostics. Competes with Curiox in pharma sample-prep automation, particularly in high-throughput immunoassay and cell-based assay workflows.

TypeBroad incumbent
Description

Thermo Fisher's lab automation portfolio (including the Orbitor plate handler referenced in Curiox's integrations) competes broadly with Curiox in pharma sample-prep automation. Also supplies flow cytometry instruments and consumables that sit downstream of Curiox's washers.

5Sony Biotechnology
TypeDirect peer
Description

Sony Biotechnology manufactures spectral flow cytometry instruments (ID7000, SA3800) and cell-sorting systems. Competes with Curiox's downstream flow workflow customers and overlaps in pharma/biotech translational research accounts.

TypeEmerging player
Description

Bio-Techne offers flow cytometry antibodies, reagents (e.g., PrimeFlow), and cell-therapy tools that intersect with Curiox's pharma and academic research customers. Provides complementary consumables for high-parameter flow cytometry panels run on Curiox workstations.

TypeDirect peer
Description

Miltenyi Biotec manufactures cell-separation and sample-prep technologies (MACS, gentleMACS, MultiMACS) plus flow cytometry instruments. Competes with Curiox in gentle cell-handling workflows for immunology, cell therapy, and translational research.

TypeBroad incumbent
Description

Hamilton is a leading manufacturer of laboratory automation and liquid-handling workstations (Microlab STAR, Vantage) used in genomics, drug discovery, and clinical diagnostics. Curiox's Pluto Code integrates directly with Hamilton platforms, and both target pharma/CRO sample-prep automation.

TypeDirect peer
Description

Cytek is a leading provider of high-parameter flow cytometry instruments (Aurora, Northern Lights) and reagents. Curiox's Pluto workstations are explicitly positioned to automate sample prep upstream of Cytek cytometers, making the companies complementary partners in the same flow workflow.

TypeBroad incumbent
Description

Danaher-owned Beckman Coulter supplies flow cytometry instruments (CytoFLEX, Navios) and the Biomek liquid-handling automation line. Overlaps with Curiox across flow cytometry sample prep workflows and serves the same pharma/biotech/clinical customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Curiox Biosystems

Laboratory Automation Instrumentationcuriox.com

Curiox Biosystems provides the C-FREE platform and Pluto product family of automated, centrifuge-free cell washing and antibody cocktailing workstations used by pharmaceutical companies, CROs, academic core facilities, and cell-therapy developers to standardize flow cytometry sample preparation.

What Curiox Biosystems does

Curiox Biosystems develops and manufactures automation solutions for suspension cell sample preparation, replacing traditional centrifugation with its proprietary C-FREE technology platform. C-FREE uses laminar flow physics and software-controlled pipetting to gently wash and mix cells and beads without centrifugation, minimizing mechanical stress, improving cell retention (reportedly up to 90.6% versus 10.5% with centrifugation), and reducing operator variability. The portfolio spans the Pluto ALPHA compact benchtop washer, the Pluto Workstation family (LT/MT/HT variants with up to 96-channel pipetting) for integrated antibody cocktailing, cell staining, and washing, and Pluto Code, a software library that deploys C-FREE wash physics onto existing Opentrons and Hamilton liquid handlers without additional hardware. Supporting tools include the Antibody Cocktailing Wizard and Workflow Wizard for protocol standardization and audit-traceable execution, plus legacy Laminar Wash HT/AUTO/MINI systems and Drop Array consumables.

The company monetizes through direct enterprise sales of hardware systems, recurring consumables (plates, reagents, accessories), and emerging enterprise software licensing via Master Software License Agreements for Pluto Code. Go-to-market is enterprise field sales targeting pharmaceutical and biotech companies, contract research organizations, academic core facilities, and cell-therapy manufacturers, with technical evaluation cycles of 4-8 weeks and quote-based pricing. Named customers include AbbVie, AstraZeneca, Amgen, Pfizer, Novartis, Bristol-Myers Squibb, Sanofi, GSK, Merck, Takeda, Kite Pharma, Stanford, NIST, IQVIA, Charles River Laboratories, Eurofins, 10x Genomics, and IMU Biosciences. Curiox completed a $15 million Series C led by Luha Private Equity in March 2022 (following a prior $15M Series B in 2019) to fund global operations expansion; it has since obtained 21 CFR Part 11 compliance, expanded presence across the US, UK, Switzerland, Germany, and France, and is listed on KOSDAQ (445680) while remaining operationally a venture-backed life-sciences tools firm with 51-100 employees.

Curiox Biosystems firmographics

Firmographics
Name
Curiox Biosystems
Legal name
Curiox Biosystems, Inc.
Website
https://curiox.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
51–100 employees
Short description
Curiox Biosystems provides the C-FREE platform and Pluto product family of automated, centrifuge-free cell washing and antibody cocktailing workstations used by pharmaceutical companies, CROs, academic core facilities, and cell-therapy developers to standardize flow cytometry sample preparation.
Ownership category
akta.pro rank

Where Curiox Biosystems is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Curiox Biosystems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Pluto Hardware Systems: Sale of Pluto Workstation (HT/MT/LT variants), Pluto ALPHA automated cell washing systems, and associated accessories and consumables. Systems range from compact benchtop to high-throughput enterprise workstations.
  2. Pluto Code Software Licensing: Enterprise software licensing model for Pluto Code deployment across liquid-handling workstations. Master Software License Agreement enables enterprise-scale activation across additional workstations and sites under master terms.
  3. Consumables and Accessories: Ongoing sales of plates, reagents, and consumables for use with Pluto systems. Includes Laminar Wash plates, Drop Array products, and lab accessories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Curiox Biosystems product offering

Product offering

Core offering

Curiox Biosystems develops and sells the C-FREE Technology Platform, an automation-ready system for centrifuge-free cell washing and sample preparation using proprietary laminar flow principles. The company sells the Pluto Workstation family (low, mid, and high throughput variants), the compact Pluto ALPHA cell washer, the Pluto Code software for deploying C-FREE on existing liquid handlers, and supporting Laminar Wash plate-based systems, consumables, and accessories to pharmaceutical, biotech, CRO, cell therapy, and academic customers.

Product overview

Curiox Biosystems offers the C-FREE Technology Platform, an automation-ready system for centrifuge-free cell washing and sample preparation. The portfolio includes Pluto ALPHA (compact cell washing), Pluto LT/MT/HT Workstations (low to high throughput automated workstations for antibody cocktailing and cell washing), and Pluto Code (software for integrating C-FREE into existing liquid handlers). Supporting this are Laminar Wash technology (plate-based gentle cell washing) and software tools like Antibody Cocktailing Wizard and Workflow Wizard. Legacy products include Laminar Wash HT2000/HT2100, AUTO 1000, and MINI1000 systems. The platform uses proprietary laminar flow principles to replace centrifugation with software-controlled pipette-based washing, enabling consistent, reproducible cell preparation for flow cytometry, single-cell sequencing, and cell therapy applications.

Differentiator

Problem solved

Functional benefit

Brands

  • C-FREE: Automation-ready platform that performs cell washing and mixing without centrifugation, powering the Pluto product family.
  • Laminar Wash
  • Pluto
  • Pluto ALPHA
  • Pluto Workstation
  • Pluto Code

Products and services

  • Pluto Workstation Automated liquid handler workstation for antibody cocktailing, cell staining, and washing. Available in three throughput variants: LT (8-channel head, up to 32 wells), MT (24-channel head, up to 72 wells), and HT (96-channel head, up to 96 wells). Supports 40+ parameter panels with temperature-controlled antibody handling, liquid-level detection, automated tip selection, full audit trail, and traceability for regulated environments.
  • Pluto ALPHA Compact liquid handler that automates cell washing for up to 96 wells inside biosafety cabinets, using pre-set protocols (Light, Moderate, Heavy). Eliminates centrifugation variability, preserves cell integrity, and targets smaller labs seeking affordable entry into automated, reproducible cell preparation.
  • Pluto Code Software library that brings C-FREE centrifuge-free cell washing technology directly to existing liquid handling platforms (Opentrons, Hamilton) via a portable script library. Enables enterprise-scale deployment of C-FREE wash physics across customer workstations and sites via Master Software License Agreements, requiring no additional hardware upgrades.
  • Laminar Wash HT2000 Automated plate-based laminar wash system for suspension cell sample preparation with robotic integration capability for high-throughput applications. Uses proprietary laminar flow to gently wash suspension cells without centrifugation, minimizing mechanical stress and improving viability versus traditional centrifugation workflows.
  • Laminar Wash AUTO 1000 All-in-one fully automated workstation using a suspension-cell sample preparation method that eliminates centrifugation. Provides walkaway capability with full traceability for suspension cell handling in flow cytometry workflows.
  • Laminar Wash MINI1000 Compact laminar wash system using a proprietary 16-well wall-less strip for daily operation and CITE-Seq protocol demonstrations in lower-throughput lab environments.
  • Drop Array Accessory product line for specialized array-based applications using Curiox drop-array technology, supporting lab workflows requiring array-based sample handling.

Quantifiable outcome

  • Cell retention rates increase to 90.6% vs 10.5% with centrifugation for lymphocyte recovery
  • +7 more outcomes

Companies that use Curiox Biosystems

Customer profile

Named customers19 records

Segments4 records

Ideal customer profiles4 records

Curiox Biosystems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature7 records

Curiox Biosystems partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Major Global Pharmaceutical OrganizationflagshipTechnology or Integration · 22 April 2026Master Software License Agreement for Pluto Code deployment across customer's liquid-handling workstations. Enables enterprise-scale activation across additional workstations and sites under master terms. Signals that centrifuge-free automation has moved beyond early adoption into enterprise-level deployment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Curiox Biosystems competitors and assessment

Company assessment

Direct peers

  • Standard BioTools (formerly Fluidigm): Standard BioTools sells mass cytometry (Helios/cyTOF) and high-parameter flow cytometry systems plus imaging mass cytometry. Overlaps with Curiox in flow cytometry sample preparation, particularly for high-dimensional immunophenotyping workflows.
  • Opentrons: Opentrons makes accessible bench-top liquid-handling robots (OT-2, Flex) widely used in pharma and academic labs. Curiox's Pluto Code runs natively on Opentrons hardware, so the two are both collaborators and adjacent competitors in the affordable lab-automation category.
  • Sony Biotechnology: Sony Biotechnology manufactures spectral flow cytometry instruments (ID7000, SA3800) and cell-sorting systems. Competes with Curiox's downstream flow workflow customers and overlaps in pharma/biotech translational research accounts.
  • Miltenyi Biotec: Miltenyi Biotec manufactures cell-separation and sample-prep technologies (MACS, gentleMACS, MultiMACS) plus flow cytometry instruments. Competes with Curiox in gentle cell-handling workflows for immunology, cell therapy, and translational research.
  • Cytek Biosciences: Cytek is a leading provider of high-parameter flow cytometry instruments (Aurora, Northern Lights) and reagents. Curiox's Pluto workstations are explicitly positioned to automate sample prep upstream of Cytek cytometers, making the companies complementary partners in the same flow workflow.

Broad incumbents

  • Tecan: Tecan is a global leader in laboratory automation (Freedom EVO, Fluent) and detection instruments for life sciences and diagnostics. Competes with Curiox in pharma sample-prep automation, particularly in high-throughput immunoassay and cell-based assay workflows.
  • Thermo Fisher Scientific (Laboratory Products): Thermo Fisher's lab automation portfolio (including the Orbitor plate handler referenced in Curiox's integrations) competes broadly with Curiox in pharma sample-prep automation. Also supplies flow cytometry instruments and consumables that sit downstream of Curiox's washers.
  • Hamilton Company: Hamilton is a leading manufacturer of laboratory automation and liquid-handling workstations (Microlab STAR, Vantage) used in genomics, drug discovery, and clinical diagnostics. Curiox's Pluto Code integrates directly with Hamilton platforms, and both target pharma/CRO sample-prep automation.
  • Beckman Coulter Life Sciences: Danaher-owned Beckman Coulter supplies flow cytometry instruments (CytoFLEX, Navios) and the Biomek liquid-handling automation line. Overlaps with Curiox across flow cytometry sample prep workflows and serves the same pharma/biotech/clinical customer base.

Emerging players

  • Bio-Techne: Bio-Techne offers flow cytometry antibodies, reagents (e.g., PrimeFlow), and cell-therapy tools that intersect with Curiox's pharma and academic research customers. Provides complementary consumables for high-parameter flow cytometry panels run on Curiox workstations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Curiox Biosystems social profiles

Digital presence

Curiox Biosystems compliance and trust

Trust signal

Compliance1 record

Curiox Biosystems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Curiox Biosystems leadership team

Management profile

Number of profiles

Profiles5 records

Curiox Biosystems funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Curiox Biosystems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curiox Biosystems

What does Curiox Biosystems do?

Curiox Biosystems develops and sells the C-FREE Technology Platform, an automation-ready system for centrifuge-free cell washing and sample preparation using proprietary laminar flow principles. The company sells the Pluto Workstation family (low, mid, and high throughput variants), the compact Pluto ALPHA cell washer, the Pluto Code software for deploying C-FREE on existing liquid handlers, and supporting Laminar Wash plate-based systems, consumables, and accessories to pharmaceutical, biotech, CRO, cell therapy, and academic customers.

Is Curiox Biosystems a public or private company?

Curiox Biosystems is a private company. It is classified as venture growth investor backed and is currently operating.

When was Curiox Biosystems founded?

Curiox Biosystems was founded in 2008. It employs 51 to 100 people.

Where is Curiox Biosystems based?

Curiox Biosystems is headquartered in Seoul, South Korea, in the Asia region.

How does Curiox Biosystems make money?

Three revenue lines are on record. Pluto Hardware Systems are the primary driver. The others are pluto Code Software Licensing and consumables and Accessories.

Who are Curiox Biosystems's main competitors?

Direct peers on record are Standard BioTools (formerly Fluidigm), Opentrons, Sony Biotechnology, Miltenyi Biotec and Cytek Biosciences. Broad incumbents are Tecan, Thermo Fisher Scientific (Laboratory Products), Hamilton Company and Beckman Coulter Life Sciences. Bio-Techne is listed as an emerging player.

Does Curiox Biosystems have an API?

No public API is recorded for Curiox Biosystems.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
News-MedicalCuriox Biosystems strengthens commercial leadership to expand adoption of centrifuge-free sample preparationCuriox Biosystems expanded its senior commercial team and formed a Strategic Advisory Board to accelerate adoption of its centrifuge-free sample preparation technology. The appointments aim to scale Pluto Workstations across laboratories and establish centrifuge-free workflows as standard practice.citybizCuriox Biosystems Expands Commercial Leadership, Forms Strategic Advisory BoardCuriox Biosystems appointed Shanin Barican as vice president of business development and Kristine Friscino as vice president of marketing, and formed a strategic advisory board with Elizabeth Woo and David Newble. The appointments aim to accelerate commercialization of its Pluto Workstations, which automate sample preparation for flow cytometry using centrifuge-free C-FREE technology.YahooCuriox Biosystems Strengthens Commercial Leadership to Expand Adoption of Centrifuge-Free Sample PreparationCuriox Biosystems announced the expansion of its commercial team and a Strategic Advisory Board to drive adoption of its Pluto Workstations for centrifuge-free sample preparation. The appointments include Shanin Barican as VP of Business Development and Kristine Friscino as VP of Marketing, with new advisory members to guide market adoption.FinancialContent Business PageCuriox Biosystems Strengthens Commercial Leadership to Expand Adoption of Centrifuge-Free Sample PreparationCuriox Biosystems expanded its commercial team and formed a Strategic Advisory Board to drive adoption of its centrifuge-free sample preparation technology. The appointments aim to scale Pluto Workstations across biopharma, CROs, and research institutions, with the SAB providing independent guidance on market adoption.The future of tradingCuriox Biosystems Q3 Net Loss Widens to KRW 5.35 BillionCuriox Biosystems reported a Q3 2026 operating loss of KRW 3.96 billion, widening 47.76% year over year, with net loss of KRW 5.35 billion, up 76.57%. Revenue rose 7.73% to KRW 1.49 billion, and nine-month revenue increased 20.93% to KRW 3.99 billion.NateCuriox Biosystems Weighs Patent Action Over Waters' New Cell Preparation System : 네이트 뉴스Curiox Biosystems is reportedly considering patent infringement action over Waters' new FACS360 Sample Preparation System, which shares functional similarities with Curiox's Pluto Workstation. The companies signed a 2025 NDA while discussing an OEM partnership, but product similarities alone do not establish infringement.Simply Wall StWe Think Curiox Biosystems (KOSDAQ:445680) Can Afford To Drive Business GrowthCuriox Biosystems had ₩11b cash and ₩9.3b annual cash burn as of June 2026, giving a 13-month runway. Its cash burn fell 15% while operating revenue rose 50% over the same period. The company could raise cash easily via share issuance.GlobeNewswireCuriox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code DeploymentCuriox Biosystems signed a master software license agreement with a major global pharmaceutical organization for deploying Pluto Code, its centrifuge-free cell washing software. The agreement allows activation across additional workstations and sites under single master terms, eliminating per-deployment negotiations. The deal signals enterprise-level adoption of the technology.GlobeNewswireCuriox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code DeploymentCuriox Biosystems announced the signing of a Master Software License Agreement with a major global pharmaceutical organization for the deployment of Pluto Code, its centrifuge-free cell washing software solution, across the customer's liquid-handling workstations. The agreement enables enterprise-scale activation across additional workstations and sites under master terms without requiring new contract negotiations for each expansion. The company stated that Pluto Code's adoption by this class of customer signals that centrifuge-free automation has moved beyond early adoption into enterprise-level deployment, reflecting both commercial and technical maturity.YahooCuriox Biosystems Launches Curiox C- Free Pluto ALPHA: Affordable, Hassle-Free Cell Washing AutomationCuriox Biosystems launched the Curiox C- Free Pluto ALPHA, a compact cell washing automation device that replaces centrifuge-based methods. Priced below $30,000, it uses a pipette head for gentle washing and supports 96-well plates, deep-well plates, and Laminar Wash plates. The device is available at SLAS2025.